<?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Allergy Asthma Immunol Res</journal-id><journal-id journal-id-type="publisher-id">AAIR</journal-id><journal-title-group><journal-title>Allergy, Asthma &#x00026; Immunology Research</journal-title></journal-title-group><issn pub-type="ppub">2092-7355</issn><issn pub-type="epub">2092-7363</issn><publisher><publisher-name>The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4168/aair.2009.1.1.36</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>No evidence of association between interleukin-13 gene polymorphism in aspirin intolerant chronic urticaria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Palikhe</surname><given-names>Nami Shrestha</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Seung-Hyun</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Gil-Soon</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Young-Min</given-names></name><xref ref-type="aff" rid="A1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Park</surname><given-names>Hae-Sim</given-names></name><xref ref-type="aff" rid="A1"/></contrib></contrib-group><aff id="A1">Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea.</aff><author-notes><corresp> Correspondence to: Hae-Sim Park, M.D., Ph.D., Department of Allergy and Rheumatology, Ajou University School of Medicine, San-5 Wonchun-dong, Youngtong-gu, Suwon 443-721, Korea. Tel: +82-2-219-5196; Fax: +82-2-219-5154; <email>hspark@ajou.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>25</day><month>9</month><year>2009</year></pub-date><volume>1</volume><issue>1</issue><fpage>36</fpage><lpage>40</lpage><history><date date-type="received"><day>24</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>02</day><month>9</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 The Korean Academy of Asthma, Allergy and Clinical Immunology &#x02022; The Korean Academy of Pediatric Allergy and Respiratory Disease</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Aspirin-intolerant chronic urticaria (AICU) is a common condition among the chronic urticaria population, but the genetic mechanism is not yet understood. In this study, the genotypes and haplotypes of three interleukin (IL)-13 polymorphisms, -1510 A&#x0003e;C, -1055C&#x0003e;T, and Arg110Gln (110G&#x0003e;A), as well as their respective clinical phenotypes were examined to determine whether genetic variants of <italic>IL-13</italic> play a role in AICU. Single-nucleotide polymorphism (SNP) genotyping was used to compare <italic>IL-13</italic> genotype and allele frequencies among 135 patients with AICU, 146 with aspirin-tolerant chronic urticaria (ATCU), and 430 normal controls (NC). Relationships among the AICU phenotype, atopy, and total IgE level were also investigated. The results failed to show a significant difference in the allele or genotype frequencies between the AICU group and either the ATCU or NC group (<italic>P</italic>&#x0003e;0.05, respectively). Haplotype analysis confirmed that there was no significant difference among the three study groups (<italic>P</italic>&#x0003e;0.05), nor was there a significant difference in atopy or total IgE level according to the three genetic polymorphisms (<italic>P</italic>&#x0003e;0.05, respectively). Our data lead to the conclusion that there is no evidence supporting genetic polymorphisms in <italic>IL-13</italic> as a genetic risk factor for the development of AICU.</p></abstract><kwd-group><kwd>aspirin</kwd><kwd><italic>IL-13</italic></kwd><kwd>urticaria</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) cause symptoms in 20-30% of patients with chronic urticaria (CU).<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref> In the Korean population, 35.7% of CU patients are affected, as confirmed by oral provocation testing.<xref ref-type="bibr" rid="B3">3</xref> Several genes are likely to be involved in the etiology and pathogenesis of aspirin-intolerant urticaria (AIU), including both the acute and chronic forms as well as intermediate phenotypes. The candidate genes include HLA-DRB1 *1302-DQB1*0609,<xref ref-type="bibr" rid="B4">4</xref> ALOX5,<xref ref-type="bibr" rid="B5">5</xref> FCER1A,<xref ref-type="bibr" rid="B6">6</xref> HNMT,<xref ref-type="bibr" rid="B7">7</xref> and FCER1G.<xref ref-type="bibr" rid="B8">8</xref></p><p>The cytokine interleukin (IL)-13 is produced primarily by activated Th2 cells<xref ref-type="bibr" rid="B9">9</xref> and is thought to play a role in the mechanisms of several atopic conditions. <italic>IL-13</italic> promotes B cell differentiation and is capable of inducing isotype-switching in B cells, resulting in the production of IgG4 and IgE.<xref ref-type="bibr" rid="B10">10</xref> Human lung mast cells express <italic>IL-13</italic>R&#x003b1;1, and activation of these cells by the cytokine for 5 days increased Fc&#x003b5;RI expression and proliferation.<xref ref-type="bibr" rid="B11">11</xref><italic>IL-13</italic> maps to chromosome 5q31, which has been implicated in the development of asthma and atopy.<xref ref-type="bibr" rid="B12">12</xref> It is a critical effector in the induction and maintenance of IgE production and IgE-mediated allergic airway responses.<xref ref-type="bibr" rid="B13">13</xref></p><p>Analyses of <italic>IL-13</italic> gene polymorphisms have produced various results depending on the specific study population. For example, genetic association studies in German<xref ref-type="bibr" rid="B14">14</xref> and Chinese populations have suggested a role for the IL13 variant Arg110Gln in the increased IgE production and atopic sensitization that characterizes allergic rhinitis, whereas this allele was found to be associated with asthma in British and Japanese populations.<xref ref-type="bibr" rid="B15">15</xref> Previous studies have reported that AICU patients had a significantly higher rate of atopy than ATCU patients and normal controls, suggesting that atopy is a risk factor for AICU.<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B8">8</xref> A study on FcER1&#x003b1; promoter polymorphisms found that the prolonged exposure of AICU patients to IgE induces the persistent accumulation and activation of mast cells and basophils via increased surface expression of high-affinity IgE receptors.<xref ref-type="bibr" rid="B6">6</xref></p><p>To identify genetic factors in the development of AICU, we analyzed the genotypes and haplotypes of three polymorphisms of <italic>IL-13</italic> to determine whether genetic variants of <italic>IL-13</italic> play an important role in AICU.</p></sec><sec sec-type="methods"><title>MATERIALS AND METHODS</title><sec><title>Study subjects and phenotyping</title><p>Two groups of CU patients, AICU (n=135) and ATCU (n=146), who were identified based on the results of n oral provocation test with up to 500 mg of aspirin (Rhonal; KunWha Pharmaceutical Co., Seoul, Korea), were enrolled in the study, as described previously.<xref ref-type="bibr" rid="B4">4</xref> AICU patients who had aspirin-intolerant asthma (AIA) were excluded. Normal healthy controls (NC; n=430) with no personal or family history of allergic diseases, or aspirin or drug hypersensitivity were recruited from the general Korean population. Informed consent was obtained from all participants, and the institutional review board of Ajou University Hospital approved this study. Skin-prick tests were performed with 55 common aeroallergens (Bencard Co., West Sussex, UK), and atopy was defined as one or more positive reactions to common inhalant allergens. Total IgE concentrations were measured using a UniCAP system (Phadia, Uppsala, Sweden), according to the manufacturer's instructions. Anti-thyroglobulin levels in serum were measured using anti-Tg (B.R.A.H.M.S Aktiengesellschaft, Hennigsdorf, Germany) and serum antimicrosomal antibodies with a thyroid peroxidase IgG ELISA (Zeus Scientific, Zierikzee, Netherlands).</p></sec><sec><title>SNP identification and genotyping</title><p>Peripheral blood samples from 40 healthy Korean volunteers were used to identify single nucleotide polymorphisms (SNPs). Genomic DNA was prepared from the blood samples using a Puregene DNA purification kit (Gentra, Minneapolis, MN, USA), according to the manufacturer's protocol.</p><p>The <italic>IL-13</italic> gene was examined for SNPs using an ABI Prism 3100 DNA analyzer (Applied Biosystems, Foster City, CA, USA). Three polymorphisms of <italic>IL-13</italic>, -1510 A&#x0003e;C, -1055C&#x0003e;T, and Arg110Gln (110G&#x0003e;A), were genotyped using a primer-extension method and a SNAPshot ddNTP primer-extension kit (Applied Biosystems). The primers used were: for <italic>IL-13</italic> -1510A&#x0003e;C, forward (F) 5'-TGTGGGAGATGCCGTGGG-3', reverse (R) 5'-TCTGACTCCCAGAAGTCTGC-3', and extension 5'-TACAGATTAGGAAACAGGCCCGTAG-3'; for <italic>IL-13</italic>-1055C&#x0003e;T, (F) 5'-AGAGAGGGTGGGAATGAC-3', (R) 5'-CCAGTCTCTGCAGGATCA-3', and extension 5'-TGTCGCCTTTTCCTGCTCTTCCCTC-3'; and for <italic>IL-13</italic> 110G&#x0003e;A, (F) 5'-AGTTTGTAAAGGACCTGCTCTTAC-3', (R) 5'-TCAGGTCCTGTCTCTGCAA-3', and extension 5'-TTAAAGAAACTTTTTCGCGAGGGAC-3'.</p></sec><sec><title>Statistical analysis</title><p>Chi-squared tests were used to detect significant departures in genotype frequency from the Hardy-Weinberg equilibrium at each SNP. Haplotypes of <italic>IL-13</italic> were analyzed using Haploview v2.0, based on the expectation maximization algorithm. Differences in the mean values of phenotypic characteristics among AICU patients were compared using the chi-squared test, or Fisher's exact test and independent <italic>t</italic>-test. Continuous variables that did not have a normal distribution, such as the levels of serum total IgE, were log-transformed. Differences in genotype frequency between groups were examined with the chi-squared test, and three logical regression models (co-dominant, dominant, recessive) were used after accounting for age and gender covariates. The level of statistical significance was set at <italic>P</italic>&#x0003c;0.05. SPSS 12.0 for Windows software (SPSS Inc., Chicago, IL, USA) was used for the statistical analyses.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>In our study, genetic associations among three genetic polymorphisms of <italic>IL-13</italic>, -1510A&#x0003e;C, -1055C&#x0003e;T, and Arg110Gln (110G&#x0003e;A), and the three study groups (AICU, ATCU, and NC) were examined. No significant association was detected between the <italic>IL-13</italic> polymorphisms and susceptibility to AICU (<italic>P</italic>&#x0003e;0.05).</p><p>Significant differences in AICU phenotypes, based on the presence of atopy and log serum total IgE levels, were found between the AICU, ATCU, and NC groups (<italic>P</italic>&#x0003c;0.001, respectively) (<xref ref-type="table" rid="T1">Table 1</xref>). However, there were no significant differences between the two CU groups with respect to allele and genotype frequencies (<italic>P</italic>&#x0003e;0.05) (<xref ref-type="table" rid="T2">Table 2</xref>). Furthermore, the three polymorphisms of <italic>IL-13</italic> were not in linkage disequilibrium.</p><p>Using Haploview 2.0 and the expectation maximization algorithm, five common haplotypes were constructed: ht1 (ACG), ht2 (CTA), ht3 (ACA), ht4 (CCG), and ht5 (CTG). Haplotype analysis further confirmed that there were no significant differences among the three study groups (<italic>P</italic>&#x0003e;0.05) (data not shown).</p><p>The relationship between the investigated genotypes of the three polymorphisms and AICU phenotype was not significantly different for atopy (<xref ref-type="table" rid="T4">Table 4</xref>) or total IgE (<xref ref-type="table" rid="T3">Table 3</xref>) according to the three different methods of analysis (<italic>P</italic>&#x0003e;0.05).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This study evaluated three AICU-susceptibility loci in the <italic>IL-13</italic> gene: two SNPs in the promoter region (-1510 A&#x0003e;C and -1055C&#x0003e;T) and one nonsynonymous SNP (Arg110Gln, 110G&#x0003e;A). In a case control study, we evaluated the three polymorphisms for evidence of association with AICU and related phenotypes. Based on the results, no evidence was found to support a significant association between these three SNPs and the diagnosis of AICU.</p><p>The cytokines <italic>IL-13</italic> and <italic>IL-4</italic> share biological properties such as isotype switching to IgE and expression of endothelial cell adhesion molecules.<xref ref-type="bibr" rid="B16">16</xref> Accordingly, it was reasonable to propose that in chronic urticaria, <italic>IL-13</italic> increases mast cell Fc&#x003b5;R1 expression and mediator release,<xref ref-type="bibr" rid="B17">17</xref> leading to the development of hives and the enhancement of cutaneous inflammation. In a previous report, patients with more frequent itch were found to have higher cytokine levels, suggesting that <italic>IL-13</italic> may serve as a serological marker of disease activity.<xref ref-type="bibr" rid="B18">18</xref></p><p>Owing to the lack of previously published data on <italic>IL-13</italic> SNPs in patients with AICU, our results cannot be compared directly with others. However, several studies showed a linkage between <italic>IL-13</italic> and a high serum total IgE level,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref> including an association of <italic>IL-13</italic> Arg110Gln with serum IgE levels in patients with asthma<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B15">15</xref> and atopic dermatitis.<xref ref-type="bibr" rid="B22">22</xref><italic>IL-13</italic> variants have been associated with airway responsiveness<xref ref-type="bibr" rid="B23">23</xref> and with eosinophil count.<xref ref-type="bibr" rid="B24">24</xref> Recently, <italic>IL-13</italic> Arg110Gln was reported to be significantly associated with reduced lung function in Korean children and adolescents.<xref ref-type="bibr" rid="B25">25</xref> Nevertheless, we found no significant association of either of the promoter SNPs or the coding SNP with AICU traits, including serum total IgE and atopy. Our findings indicate that a genetic variation in the form of any of the three SNPs at the <italic>IL-13</italic> locus is not likely to be involved in the development of AICU.</p><p>This result is consistent with an earlier report showing that there was no relationship between the coding SNP and allergic rhinitis induced by artemisia pollen and/or DerpI in a Chinese population. Marginal significance was found for atopy-related phenotypes associated with the Arg110Gln variant and in vitro specific IgE responses to common inhalant allergens.<xref ref-type="bibr" rid="B26">26</xref> In our previous study, two SNPs, at Fc&#x003b5;R1&#x003b2; E237G and Fc&#x003b5;R1&#x003b3;, were associated with atopy in AICU patients, but not in ATCU patients, and were proposed to explain the increased release of histamine from basophils and subsequent development of the AICU phenotype.<xref ref-type="bibr" rid="B8">8</xref> Furthermore, other studies have noted a significant association of the Fc&#x003b5;R1&#x003b2;-109T&#x0003e;C and Fc&#x003b5;R1&#x003b2; E237G polymorphisms with serum IgE levels in asthmatic patients,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref> and the Fc&#x003b5;R1&#x003b1; -344C&#x0003e;T polymorphism in AICU.<xref ref-type="bibr" rid="B6">6</xref> However, in our study, <italic>IL-13</italic> genetic polymorphisms were not related to either atopy or total IgE levels in AICU patients, implying that neither the two SNPs in the functional promoter nor the SNP in the coding sequence contribute significantly to AICU susceptibility. This is the first detailed investigation showing the absence of a genetic association between <italic>IL-13</italic> and AICU and its phenotypes, <italic>i.e.</italic>, serum total IgE and atopy. There is no evidence that these three SNPs are associated with AICU; instead, SNPs of <italic>IL-13</italic> may confer a greater susceptibility to asthma or other inflammatory diseases.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This study was supported by a grant of the Korean Health 21 R&#x00026;D Project, <funding-source>Ministry For Health, Welfare and Family Affairs, Republic of Korea</funding-source> (<award-id>A050571</award-id> and <award-id>A030001</award-id>).</p></ack><fn-group><fn fn-type="conflict"><p>There are no financial or other issues that might lead to conflict of interest.</p></fn></fn-group><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grattan</surname><given-names>CE</given-names></name></person-group><article-title>Aspirin sensitivity and urticaria</article-title><source>Clin Exp Dermatol</source><year>2003</year><volume>28</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">12653694</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mastalerz</surname><given-names>L</given-names></name><name><surname>Setkowicz</surname><given-names>M</given-names></name><name><surname>Sanak</surname><given-names>M</given-names></name><name><surname>Szczeklik</surname><given-names>A</given-names></name></person-group><article-title>Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>113</volume><fpage>771</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">15100686</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Nahm</surname><given-names>DI</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Nahm</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Comparison of clinical characteristics and prognosis of chronic urticaria according to the aspirin sensitivity</article-title><source>J Asthma Allergy Clin Immunol</source><year>2005</year><volume>25</volume><fpage>194</fpage><lpage>199</lpage></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Shin</surname><given-names>ES</given-names></name><name><surname>Oh</surname><given-names>HB</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Nahm</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria</article-title><source>Clin Exp Allergy</source><year>2005</year><volume>35</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">15784113</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Holloway</surname><given-names>JW</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Nahm</surname><given-names>DH</given-names></name><name><surname>Ha</surname><given-names>EH</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population</article-title><source>J Korean Med Sci</source><year>2005</year><volume>20</volume><fpage>926</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">16361798</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Ye</surname><given-names>YM</given-names></name><name><surname>Yoon</surname><given-names>HJ</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Nahm</surname><given-names>DH</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Significant association of FcepsilonRIalpha promoter polymorphisms with aspirin-intolerant chronic urticaria</article-title><source>J Allergy Clin Immunol</source><year>2007</year><volume>119</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">17125826</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Cho</surname><given-names>BY</given-names></name><name><surname>Ye</surname><given-names>YM</given-names></name><name><surname>Hur</surname><given-names>GY</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Histamine N-methyltransferase 939A&#x0003e;G polymorphism affects mRNA stability in patients with acetylsalicylic acid-intolerant chronic urticaria</article-title><source>Allergy</source><year>2009</year><volume>64</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">19178400</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palikhe</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Yang</surname><given-names>EM</given-names></name><name><surname>Kang</surname><given-names>YM</given-names></name><name><surname>Ye</surname><given-names>YM</given-names></name><name><surname>Hur</surname><given-names>GY</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name></person-group><article-title>Analysis of high-affinity IgE receptor (FcepsilonR1) polymorphisms in patients with aspirin-intolerant chronic urticaria</article-title><source>Allergy Asthma Proc</source><year>2008</year><volume>29</volume><fpage>250</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">18534082</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>S</given-names></name><name><surname>Hashimoto</surname><given-names>S</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Toyoda</surname><given-names>N</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name></person-group><article-title>Comprehensive gene expression profile of human activated T(h)1- and T(h)2-polarized cells</article-title><source>Int Immunol</source><year>2001</year><volume>13</volume><fpage>367</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">11222506</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cocks</surname><given-names>BG</given-names></name><name><surname>de Waal Malefyt</surname><given-names>R</given-names></name><name><surname>Galizzi</surname><given-names>JP</given-names></name><name><surname>de Vries</surname><given-names>JE</given-names></name><name><surname>Aversa</surname><given-names>G</given-names></name></person-group><article-title>IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand</article-title><source>Int Immunol</source><year>1993</year><volume>5</volume><fpage>657</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">7688562</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>D</given-names></name><name><surname>Hollins</surname><given-names>F</given-names></name><name><surname>Woodman</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Monk</surname><given-names>P</given-names></name><name><surname>May</surname><given-names>R</given-names></name><name><surname>Bradding</surname><given-names>P</given-names></name><name><surname>Brightling</surname><given-names>CE</given-names></name></person-group><article-title>Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression</article-title><source>Allergy</source><year>2006</year><volume>61</volume><fpage>1047</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">16918506</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakawa</surname><given-names>I</given-names></name><name><surname>Deichmann</surname><given-names>KA</given-names></name><name><surname>Izuhara</surname><given-names>I</given-names></name><name><surname>Mao</surname><given-names>I</given-names></name><name><surname>Adra</surname><given-names>CN</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name></person-group><article-title>Atopy and asthma: genetic variants of IL-4 and IL-13 signalling</article-title><source>Immunol Today</source><year>2000</year><volume>21</volume><fpage>60</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">10652462</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Pouw Kraan</surname><given-names>TC</given-names></name><name><surname>van Veen</surname><given-names>A</given-names></name><name><surname>Boeije</surname><given-names>LC</given-names></name><name><surname>van Tuyl</surname><given-names>SA</given-names></name><name><surname>de Groot</surname><given-names>ER</given-names></name><name><surname>Stapel</surname><given-names>SO</given-names></name><name><surname>Bakker</surname><given-names>A</given-names></name><name><surname>Verweij</surname><given-names>CL</given-names></name><name><surname>Aarden</surname><given-names>LA</given-names></name><name><surname>van der Zee</surname><given-names>JS</given-names></name></person-group><article-title>An IL-13 promoter polymorphism associated with increased risk of allergic asthma</article-title><source>Genes Immun</source><year>1999</year><volume>1</volume><fpage>61</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">11197307</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wills-Karp</surname><given-names>M</given-names></name><name><surname>Chiaramonte</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-13 in asthma</article-title><source>Curr Opin Pulm Med</source><year>2003</year><volume>9</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12476080</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>PE</given-names></name><name><surname>Kabesch</surname><given-names>M</given-names></name><name><surname>Halonen</surname><given-names>M</given-names></name><name><surname>Holberg</surname><given-names>CJ</given-names></name><name><surname>Baldini</surname><given-names>M</given-names></name><name><surname>Fritzsch</surname><given-names>C</given-names></name><name><surname>Weiland</surname><given-names>SK</given-names></name><name><surname>Erickson</surname><given-names>RP</given-names></name><name><surname>von Mutius</surname><given-names>E</given-names></name><name><surname>Martinez</surname><given-names>FD</given-names></name></person-group><article-title>A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children</article-title><source>J Allergy Clin Immunol</source><year>2000</year><volume>105</volume><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">10719301</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kang</surname><given-names>DS</given-names></name><name><surname>Choi</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>WJ</given-names></name><name><surname>Ro</surname><given-names>JY</given-names></name></person-group><article-title>Increased expression of endothelial cell adhesion molecules due to mediator release from human foreskin mast cells stimulated by autoantibodies in chronic urticaria sera</article-title><source>J Invest Dermatol</source><year>2002</year><volume>118</volume><fpage>658</fpage><lpage>663</lpage><pub-id pub-id-type="pmid">11918713</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryzhov</surname><given-names>S</given-names></name><name><surname>Goldstein</surname><given-names>AE</given-names></name><name><surname>Matafonov</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>D</given-names></name><name><surname>Biaggioni</surname><given-names>I</given-names></name><name><surname>Feoktistov</surname><given-names>I</given-names></name></person-group><article-title>Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><fpage>7726</fpage><lpage>7733</lpage><pub-id pub-id-type="pmid">15187156</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caproni</surname><given-names>M</given-names></name><name><surname>Cardinali</surname><given-names>C</given-names></name><name><surname>Giomi</surname><given-names>B</given-names></name><name><surname>Antiga</surname><given-names>E</given-names></name><name><surname>D'Agata</surname><given-names>A</given-names></name><name><surname>Walter</surname><given-names>S</given-names></name><name><surname>Fabbri</surname><given-names>P</given-names></name></person-group><article-title>Serological detection of eotaxin, IL-4, IL-13, IFN-gamma, MIP-1alpha, TARC and IP-10 in chronic autoimmune urticaria and chronic idiopathic urticaria</article-title><source>J Dermatol Sci</source><year>2004</year><volume>36</volume><fpage>57</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">15488706</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>E</given-names></name><name><surname>Shibasaki</surname><given-names>M</given-names></name><name><surname>Arinami</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Maki</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Hamaguchi</surname><given-names>H</given-names></name></person-group><article-title>Evidence for linkage between asthma/atopy in childhood and chromosome 5q31-q33 in a Japanese population</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>156</volume><fpage>1390</fpage><lpage>1393</lpage><pub-id pub-id-type="pmid">9372650</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>LJ</given-names></name><name><surname>Daniels</surname><given-names>SE</given-names></name><name><surname>Rye</surname><given-names>PJ</given-names></name><name><surname>Gibson</surname><given-names>NA</given-names></name><name><surname>Tay</surname><given-names>GK</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Goldblatt</surname><given-names>J</given-names></name><name><surname>Burton</surname><given-names>PR</given-names></name><name><surname>LeSouef</surname><given-names>PN</given-names></name></person-group><article-title>Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children</article-title><source>Am J Respir Crit Care Med</source><year>1998</year><volume>158</volume><fpage>1825</fpage><lpage>1830</lpage><pub-id pub-id-type="pmid">9847274</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeMeo</surname><given-names>DL</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Silverman</surname><given-names>EK</given-names></name><name><surname>Senter</surname><given-names>JM</given-names></name><name><surname>Drazen</surname><given-names>JM</given-names></name><name><surname>Barth</surname><given-names>MJ</given-names></name><name><surname>Laird</surname><given-names>N</given-names></name><name><surname>Weiss</surname><given-names>ST</given-names></name></person-group><article-title>Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program</article-title><source>Genet Epidemiol</source><year>2002</year><volume>23</volume><fpage>335</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">12432502</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzmann</surname><given-names>A</given-names></name><name><surname>Mao</surname><given-names>XQ</given-names></name><name><surname>Akaiwa</surname><given-names>M</given-names></name><name><surname>Kreomer</surname><given-names>RT</given-names></name><name><surname>Gao</surname><given-names>PS</given-names></name><name><surname>Ohshima</surname><given-names>K</given-names></name><name><surname>Umeshita</surname><given-names>R</given-names></name><name><surname>Abe</surname><given-names>Y</given-names></name><name><surname>Braun</surname><given-names>S</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Roberts</surname><given-names>MH</given-names></name><name><surname>Sugimoto</surname><given-names>R</given-names></name><name><surname>Arima</surname><given-names>K</given-names></name><name><surname>Arinobu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Kruse</surname><given-names>S</given-names></name><name><surname>Enomoto</surname><given-names>T</given-names></name><name><surname>Dake</surname><given-names>Y</given-names></name><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Shimazu</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Adra</surname><given-names>CN</given-names></name><name><surname>Kitaichi</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Yamauchi</surname><given-names>K</given-names></name><name><surname>Tomichi</surname><given-names>N</given-names></name><name><surname>Kurimoto</surname><given-names>F</given-names></name><name><surname>Hamasaki</surname><given-names>N</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name><name><surname>Izuhara</surname><given-names>K</given-names></name><name><surname>Shirakawa</surname><given-names>T</given-names></name><name><surname>Deichmann</surname><given-names>KA</given-names></name></person-group><article-title>Genetic variants of IL-13 signalling and human asthma and atopy</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>549</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">10699178</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>TD</given-names></name><name><surname>Whittaker</surname><given-names>PA</given-names></name><name><surname>Zaiman</surname><given-names>AL</given-names></name><name><surname>Koppelman</surname><given-names>GH</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Hanley</surname><given-names>MT</given-names></name><name><surname>Meyers</surname><given-names>DA</given-names></name><name><surname>Postma</surname><given-names>DS</given-names></name><name><surname>Bleecker</surname><given-names>ER</given-names></name></person-group><article-title>Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population</article-title><source>Am J Respir Cell Mol Biol</source><year>2001</year><volume>25</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">11588017</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunninghake</surname><given-names>GM</given-names></name><name><surname>Soto-Quiros</surname><given-names>ME</given-names></name><name><surname>Avila</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>A</given-names></name><name><surname>Demeo</surname><given-names>DL</given-names></name><name><surname>Ly</surname><given-names>NP</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Sylvia</surname><given-names>JS</given-names></name><name><surname>Klanderman</surname><given-names>BJ</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Raby</surname><given-names>BA</given-names></name><name><surname>Silverman</surname><given-names>EK</given-names></name><name><surname>Celedon</surname><given-names>JC</given-names></name></person-group><article-title>Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood</article-title><source>J Allergy Clin Immunol</source><year>2007</year><volume>120</volume><fpage>84</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17561245</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HW</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Min</surname><given-names>KU</given-names></name><name><surname>Kim</surname><given-names>YY</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name></person-group><article-title>Genetic variation of IL13 as a risk factor of reduced lung function in children and adolescents: a cross-sectional population-based study in Korea</article-title><source>Respir Med</source><year>2009</year><volume>103</volume><fpage>284</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">18815020</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieters</surname><given-names>A</given-names></name><name><surname>Linseisen</surname><given-names>J</given-names></name><name><surname>Becker</surname><given-names>N</given-names></name></person-group><article-title>Association of polymorphisms in Th1, Th2 cytokine genes with hay-fever and atopy in a subsample of EPIC-Heidelberg</article-title><source>Clin Exp Allergy</source><year>2004</year><volume>34</volume><fpage>346</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">15005726</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>RP</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name><name><surname>Lynch</surname><given-names>JR</given-names></name><name><surname>Faux</surname><given-names>JA</given-names></name><name><surname>Lathrop</surname><given-names>GM</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Hopkin</surname><given-names>JM</given-names></name></person-group><article-title>Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13</article-title><source>J Med Genet</source><year>1992</year><volume>29</volume><fpage>236</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">1583642</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hizawa</surname><given-names>N</given-names></name><name><surname>Yamaguchi</surname><given-names>E</given-names></name><name><surname>Jinushi</surname><given-names>E</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name></person-group><article-title>A common FCER1B gene promoter polymorphism influences total serum IgE levels in a Japanese population</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>906</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">10712341</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Clinical characteristics of study subjects</p></caption><graphic xlink:href="aair-1-36-i001"/><table-wrap-foot><fn><p>Values in bold indicate significant <italic>P</italic> value. The value was presented as means&#x000b1;S.D.</p><p>NA=not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Allele and genotype frequencies of AICU</p></caption><graphic xlink:href="aair-1-36-i002"/><table-wrap-foot><fn><p>Each <italic>P</italic> value was calculated with co-dominant, dominant, and recessive models. Logistic regression analysis was applied to control for age and sex as covariables. q; Minor allele frequency.</p><p>AICU, aspirin-intolerant chronic urticaria; NC, normal controls; ATCU, aspirin-tolerant chronic urticaria; N, number of patients.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of the log total IgE according to the genotype of IL 13 in AICU</p></caption><graphic xlink:href="aair-1-36-i003"/><table-wrap-foot><fn><p>The value was presented as means&#x000b1;S.D.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison of the atopy (presence/total) according to the genotype of IL 13 in AICU</p></caption><graphic xlink:href="aair-1-36-i004"/></table-wrap></floats-group></article>